Diabetes Drug “Jardiance” Cuts Cardiovascular Deaths

Cardiovascular deaths are reduced by 38% among Jardiance users, new study published by The New England Journal of Medicine shows Jardiance, a modern diabetes drug sold by Eli Lilly and Boehringer Ingelheim, has been shown to reduce deaths from cardiovascular disease by 38%, researchers announced on Thursday at the annual meeting of the European Association […]

Read More